IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.970
-0.030 (-1.50%)
At close: Jan 30, 2026, 4:00 PM EST
2.000
+0.030 (1.52%)
After-hours: Jan 30, 2026, 7:59 PM EST
IN8bio Market Cap
IN8bio has a market cap or net worth of $19.24 million as of January 30, 2026. Its market cap has decreased by -12.40% in one year.
Market Cap
19.24M
Enterprise Value
11.51M
1-Year Change
-12.40%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $19.24M, a decrease of -89.74%. That is a compound annual growth rate of -39.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 19.24M | 94.91% |
| Dec 31, 2025 | 9.87M | -47.05% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 20.91M |
| Jupiter Neurosciences | 20.66M |
| Klotho Neurosciences | 20.39M |
| CASI Pharmaceuticals | 20.34M |
| Pasithea Therapeutics | 19.86M |
| Lunai Bioworks | 19.68M |
| Quantum BioPharma | 18.87M |
| VYNE Therapeutics | 18.86M |